medigraphic.com
ISSN 1561-302X (Print)

2021, Number 3

<< Back Next >>

Rev cubana med 2021; 60 (3)

Overuse of the neutrophil cytoplasmic antibody test

Kokuina E, Dalas GM

Language: Spanish
References: 12
Page: 1-5
PDF size: 229.91 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Csernok E. New concepts in ANCA detection and disease classification in small vessel vasculitis: the role of ANCA antigen specificity. Mediterr J Rheumatol. 2018;29(1):17-20. Disponible en: https://doi.org/10.31138/mjr.29.1.17

  2. Weiner M, Segelmark M. The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmun Rev. 2016;15:978-82. Disponible en: https://doi.org/10.1016/j.autrev.2016.07.016

  3. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. Disponible en: https://doi.org/10.1002/art.37715

  4. Fussner LA, Hummel AM, Schroeder DR. Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3. Arthritis Rheumatol. 2016;68(7):1700-10.

  5. Allard-Chamard H, Liang P. Antineutrophil Cytoplasmic antibodies testing and interpretation. Clin Lab Med. 2019;39:539-52. Disponible en: https://doi.org/10.1016/j.cll.2019.07.003

  6. Mandl LA, Solomon DH, Smith EL, Robert A Lew, Jeffrey N Katz, Robert H Shmerling. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy? Arch Intern Med. 2002;162(13):1509-14. Disponible en: https://doi.org/10.1001/archinte.162.13.1509

  7. Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T, et al. Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol. 2014;66(6):1672-7. Disponible en: https://doi.org/10.1002/art.38389

  8. Generini S, Ermini M, Taccetti G, Trapani S, Cerinic MM, Falcini F. Clinical and laboratory features and disease outcome of Kawasaki disease: the analysis of our experience and literature review. J Clin Rheumatol. 1997;3(5):241-7. Disponible en: https://doi.org/10.1097/00124743-199710000-000

  9. Ronda N, Esnault VL, Layward L, Sepe V, Allen A, Feehally J, et al. Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schonlein purpura. Clin Exp Immunol. 1994;95(1):49-55. Disponible en: https://doi.org/10.1111/j.1365-2249.1994.tb06013.x

  10. Wong RC, Silvestrini RA, Savige JA, Fulcher DA, Benson EM. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns. J Clin Pathol. 1999;52(2):124-8. Disponible en: https://doi.org/10.1136/jcp.52.2.124

  11. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem. 2006;52:171-81. Disponible en: https://doi.org/10.1373/clinchem.2005.058560

  12. Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, et al. Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13(11):683-92. Disponible en: https://doi.org/10.1038/nrrheum,2017.140




2020     |     www.medigraphic.com